InvestorsHub Logo

PURA VIDA

08/21/23 9:42 AM

#2768 RE: john cupo #2767

You already know the answer to that - they couldn't do anything positive with 14 Million.
And, really, they got 250K for the first installment - when it was supposed to be 2 Million... do you
really think the other money will come in as planned ? Maybe - but for me - doubtful.

With a "HUGE" 71.1 Million shares outstanding and the Ionic debt hanging over their heads - and their current payables and other debt - that's a drop in the bucket. As well, you are aware that Nicole baby has been onboard for nearly 3 years now - and what's that done ??? They run this like a business being run out of a teenager's basement. DTC advertising etc. They don't even like selling at the big-box stores because in order to do that, they have to give the product away so the big box stores can make profit. (as well, they don't have the money to keep that amount of inventory on hand)

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172598456

Anyhow, it's still a real uphill battle for this ticker.
Bearish
Bearish

ProfitScout

08/21/23 11:44 AM

#2771 RE: john cupo #2767

Yes, very good news for AVRW with $2,000,000.00 of additional funding coming into the company at this time per the latest 10Q filing (See excerpt below, Page 39 of the filing under NOTE 20). This funding boost plus the rising revenues from sales of the company's increasingly successful Seratopical Revolution product line should accelerate the company's advance towards profitability and an up-listing to higher tier trading exchange.
Link:
https://www.otcmarkets.com/filing/html?id=16863859&guid=wfN-keRV-t5HJth

NOTE 20 – SUBSEQUENT EVENTS
The Company has evaluated subsequent events through the filing date of this Quarterly Report, August 14, 2023, and there are no subsequent events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements other than the following: On July 31, 2023, the Company entered into a letter agreement (the “Agreement”) with Cure Pharmaceutical, Inc. (f/k/a TF Tech Ventures, Inc.) which extended the July 22, 2023 maturity date of the $2.0 million note receivable received in connection with the Asset Sale. Pursuant to the Agreement, the repayment to the Company will be made in three installments, as follows: $250 thousand within one day of the signing of the Agreement; $250 thousand no later than the earlier of 10 business days or 12 calendar days from the date of the first installment payment; and the remaining balance including accrued interest no later than 30 days from the date of the first installment payment. The Company received the first installment payment in the amount of $250 thousand on August 1, 2023.
Bullish
Bullish